Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A National, Prospective, Randomized, Multicenter, Controlled Comparison of Bioactive Glass S53P4 Versus Standard of Care Treatment of Diabetic Foot Osteomyelitis in the Forefoot

NCT06388603 is registered in ClinicalTrials.gov with ASST Ovest Milanese as lead sponsor.

NCT NCT06388603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06388603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A National, Prospective, Randomized, Multicenter, Controlled Comparison of Bioactive Glass S53P4 Versus Standard of Care Treatment of Diabetic Foot Osteomyelitis in the Forefoot
Lead sponsor
ASST Ovest Milanese
Phase
Not applicable
Overall status
Recruiting
Start date
March 21, 2024
Completion date
December 30, 2026
Enrollment
140 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

osteomyelitis - foot